JP:4516 Stock Latest News
Company AnnouncementsNippon Shinyaku Reports Six-Month Revenue Growth, Lower Profits1w ago
Company AnnouncementsNippon Shinyaku Completes Treasury Share Disposal for Director Stock Compensation3M ago
Company AnnouncementsNippon Shinyaku Delivers Strong Q1 Results and Confirms Stable Full-Year Outlook3M ago
Company AnnouncementsNippon Shinyaku Uses Restricted Stock to Tighten Director-Shareholder Alignment4M ago4516
Company AnnouncementsNippon Shinyaku Posts Revenue Growth but Lower Profit, Keeps Dividend Steady6M ago4516
Company AnnouncementsNS-863 Phase 2 Trial Positions Nippon Shinyaku for a New Niche in Pulmonary Hypertension8M ago4516Company AnnouncementsNippon Shinyaku’s NS-863 PAH Trial: Early-Stage Catalyst in a Competitive Specialty Market8M ago4516
Company AnnouncementsNippon Shinyaku Revamps Board Lineup Ahead of June Shareholders’ Meeting9M ago4516
Company AnnouncementsNippon Shinyaku Posts Higher Revenue but Lower Profit, Keeps Dividend Plan Intact9M ago4516
Company AnnouncementsNippon Shinyaku Reports Mixed Financial Results for H1 20251y ago4516
Company AnnouncementsNippon Shinyaku’s Promising DMD Study: What Investors Need to Know1y ago4516
Company AnnouncementsNippon Shinyaku’s Promising Phase 2 Study for Duchenne Muscular Dystrophy1y ago4516
Company AnnouncementsNippon Shinyaku’s Promising Phase 2 Trial for Autoimmune Treatment1y ago4516Company AnnouncementsNippon Shinyaku Completes Treasury Stock Disposal for Executive Compensation1y ago4516
Company AnnouncementsNippon Shinyaku Reports Q1 2025 Financial Results with Mixed Performance1y ago4516
Company AnnouncementsNippon Shinyaku Implements Restricted Stock Compensation Plan1y ago4516
Company AnnouncementsNippon Shinyaku Advances Corporate Governance and Diversity2y ago4516
Company AnnouncementsNippon Shinyaku Advances Corporate Governance2y ago4516



